OncoGenex Pharmaceuticals reports financial results for fourth quarter and year end
OncoGenex reported the net loss for the fourth quarter and 2014 year-end was $5.7 million, and $26.2 million, respectively. Revenue for the 2014 year end was $27.1 million versus $29.9 million in 2013. The company had $47.1 million in cash and equivalents as of December 31, 2014. March 26, 2015